INTERLIVER is a prospective observational study of the relationship of the molecular phenotype of 300 liver transplant biopsies to the histologic phenotype and the clinical features and outcomes. A segment of a biopsy performed as standard-of-care for indications, or by center protocol, will be used for gene expression study.
Liver Dysfunction
INTERLIVER is a prospective observational study of the relationship of the molecular phenotype of 300 liver transplant biopsies to the histologic phenotype and the clinical features and outcomes. A segment of a biopsy performed as standard-of-care for indications, or by center protocol, will be used for gene expression study.
Diagnostic and Therapeutic Applications of Microarrays in Liver Transplantation
-
University of California San Francisco, Transplant Research Unit, San Francisco, California, United States, 94143
Northwestern Memorial Hospital, Chicago, Illinois, United States, 60611
University of Maryland School of Medicine, Baltimore, Maryland, United States, 21201
Henry Ford Transplant Institute, Detroit, Michigan, United States, 48202
Vanderbilt University Medical Center, Vanderbilt Transplant Center, Nashville, Tennessee, United States, 37232
Baylor University Medical Center, Annette C. and Harold C. Simmons Transplant Institute, Dallas, Texas, United States, 75246
Transplant Surgery, VCU Medical Center, Richmond, Virginia, United States, 23298
Division of Transplant Surgery, University of Washington, Seattle, Washington, United States, 98195
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to
ALL
No
University of Alberta,
Philip F Halloran, MD, PhD, PRINCIPAL_INVESTIGATOR, University of Alberta
2026-12